Induction of cell differentiation in human leukemia U-937 cells by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon polystachyum

The present study focused on the effect of a series of extracts and two 5,6,7-trioxygenated coumarins isolated from Pterocaulon polystachyum on the proliferation and differentiation of human promonocytic U-937 cells. The petroleum ether extract was the only extract that significantly reduced cell pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Riveiro, M.E
Otros Autores: Shayo, C., Monczor, F., Fernández, N., Baldi, A., De Kimpe, N., Rossi, J., Debenedetti, S., Davio, C.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2004
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 14994caa a22015017a 4500
001 PAPER-4497
003 AR-BaUEN
005 20230518203403.0
008 190411s2004 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-2942555106 
024 7 |2 cas  |a Coumarins; Plant Extracts 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a CALED 
100 1 |a Riveiro, M.E. 
245 1 0 |a Induction of cell differentiation in human leukemia U-937 cells by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon polystachyum 
260 |c 2004 
270 1 0 |m Davio, C.; Laboratorio de Radioisótopos, Fac. de Farmacia Y Bioquímica, Universidad de Buenos Aires, Junín 956 PB, 1113, Capital Federal, Buenos Aires, Argentina; email: cardavio@ffyb.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., Fisher, P.B., Differentiation therapy of human cancer: Basic science and clinical applications (2001) Pharmacol. Ther., 90, pp. 105-156 
504 |a Domen, J., Weissman, I.L., Self-renewal, differentiation or death: Regulation and manipulation of hematopoietic stem cell fate (1999) Mol. Med. Today, 5, pp. 201-208 
504 |a Drach, J., McQueen, T., Engel, H., Andreeff, M., Robertson, K., Collins, S.J., Malavasi, F., Mehta, K., Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha (1994) Cancer Res., 54, pp. 1746-1752 
504 |a Lawrence, R.N., Rediscovering natural product biodiversity (1999) Drug Discov. Today, 4, pp. 449-451 
504 |a Fujioka, T., Furumi, K., Fujii, H., Okabe, H., Mihashi, K., Nakano, Y., Matsunaga, H., Mori, M., Antiproliferative constituents from umbelliferae plants. V. A new furanocoumarin and falcarindiol furanocoumarin ethers from the root of Angelica japonica (1999) Chem. Pharm. Bull., 47, pp. 96-100 
504 |a Kofinas, C., Chinou, L., Loukis, A., Harvala, C., Roussakis, C., Maillard, M., Hostettmann, K., Cytotoxic coumarins from the aerial parts of Tordylium apulum and their effects on a non-small-cell bronchial carcinoma cell line (1998) Planta Med., 64, pp. 174-176 
504 |a Kawaii, S., Tomono, Y., Ogawa, K., Sugiura, M., Yano, M., Yoshizawa, Y., The antiproliferative effect of coumarins on several cancer cell lines (2001) Anticancer Res., 21, pp. 917-923 
504 |a Murray, R.D.H., Méndez, J., Brown, R.A., (1982) The Natural Coumarins: Occurrence, Chemistry and Biochemistry, , New York, NY: Wiley 
504 |a Murray, R.D., Coumarins (1991) Progress in the Chemistry of Organic Natural Products, pp. 83-316. , W. Herz, G.W. Kirby, W. Steglich, & C. Tamm. New York, NY: Springer 
504 |a Murray, R.D., Coumarins (1997) Progress in the Chemistry of Organic Natural Products, pp. 2-119. , W. Herz, G.W. Kirby, W. Steglich, & C. Tamm. New York, NY: Springer 
504 |a Murray, R.D.H., Coumarins (1989) Nat. Prod. Rep., 8, pp. 591-624 
504 |a Hoult, J., Paya, M., Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential (1996) Gen. Pharmacol., 27, pp. 713-722 
504 |a Egan, D., O'Kennedy, R., Moran, E., Thornes, R.D., The pharmacology, metabolism, analysis and applications of coumarin and coumarin related compounds (1990) Drug Metab. Rev., 22, pp. 503-529 
504 |a Laurin, P., Klich, M., Dupis-Hamelin, C., Mauvais, P., Lassaigne, P., Bonnefoy, A., Musicki, B., Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B (1999) Bioorg. Med. Chem. Lett., 9, pp. 2079-2084 
504 |a Pillai, S., Menon, S., Mitscher, L., Pillai, C., Shankel, D., Umbelliferone analogues and their potential to inhibit benzo(a)pyrene and hydrogen peroxide induced mutations (1999) J. Nat. Prod., 62, pp. 1358-1362 
504 |a Lin, W.L., Wang, C.J., Tsai, Y.Y., Liu, C.L., Hwang, J.M., Tseng, T.H., Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver (2000) Arch. Toxicol., 74, pp. 467-472 
504 |a Roma, G., Braccio, M.D., Carrieri, A., Grossi, G., Leoncini, G., Grazia Signorello, M., Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: Synthesis, biological evaluation, and comparative molecular field analysis (2003) Bioorg. Med. Chem., 11, pp. 123-138 
504 |a Kirkiacharian, S., Thuy, D.T., Sicsic, S., Bakhchinian, R., Kurkjian, R., Tonnaire, T., Structure-activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1 protease inhibitors (2002) Farmaco, 57, pp. 703-708 
504 |a Seliger, B., (1997) The Effects of Coumarin and Its Metabolites on Cell Growth and Development, pp. 93-102. , R. O'Kennedy, & R.D. Thornes 
504 |a Zlabinger, G.J., (1997) Coumarin As An Immunomodulator, pp. 103-124. , R. O'Kennedy, & R.D. Thornes 
504 |a Noguchi, M., Earashi, M., Minami, M., Miyazaki, I., Tanaka, M., Sasaki, T., Effects of piroxicam and esculetin on the MDA-MB-231 human (1995) Prostaglandins Leukot. Essent. Fatty Acids, 53, pp. 325-329 
504 |a Chimichi, S., Boccalini, M., Cosimelli, B., Viola, G., Vedaldi, D., Dall'Acqua, F., New geiparvarin analogues from 7-(2-oxoethoxy)coumarins as efficient in vitro antitumoral agents (2002) Tetrahedron Lett., 43, pp. 7473-7476 
504 |a Jimenez-Orozco, F.A., Molina-Guarneros, J.A., Mendoza-Patino, N., Leon-Cedeno, F., Flores-Perez, B., Santos-Santos, E., Cytostatic activity of coumarin metabolites and derivatives in the B16-F10 murine melanoma cell line (1999) Melanoma Res., 9, pp. 243-247 
504 |a Hofmanova, J., Kozubik, A., Kusek, L., Pachemik, J., Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells (1998) Eur. J. Pharmacol., 350, pp. 273-284 
504 |a Palacios, R.S., Rojo, A.A., Coussio, J.D., De Kimpe, N., Debenedetti, S.L., 6,7-Dioxygenated and 5,6,7-trioxygenated coumarins from Pterocaulon polystachyum (1999) Planta Med., 65, pp. 294-295 
504 |a Mongelli, E., Pampuro, S., Coussio, J.D., Salomon, H., Ciccia, G., Cytotoxic and DNA interaction activities of extracts from medicinal plants used in Argentina (2000) J. Ethnopharmacol., 71, pp. 145-151 
504 |a Sundstrom, C., Nilsson, K., Establishment and characterization of a human histiocytic lymphoma cell line (U-937) (1976) Int. J. Cancer, 17, pp. 565-577 
504 |a Harris, P., Ralph, P., Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines (1985) J. Leukoc. Biol., 37, pp. 407-422 
504 |a Gavison, R., Matzner, Y., Fibach, E., Differential induction of monocytic functions by dibutyryl cyclic AMP and retinoic acid in a human monoblast cell line U937 (1988) Isr. J. Med. Sci., 24, pp. 697-701 
504 |a Shayo, C., Davio, C., Brodsky, A., Mladovan, A.G., Legnazzi, B.L., Rivera, E., Histamine modulates the expression of c-fos through cyclic AMP production via the H2 receptor in the human promonocytic cell line U937 (1997) Mol. Pharmacol., 51, pp. 983-990 
504 |a Grynkiewicz, G., Poenie, M., Tsien, R.Y., A new generation of Ca2+ indicators with greatly improved fluorescence properties (1985) J. Biol. Chem., 260, pp. 3440-3450 
504 |a Burg, M., Martin, U., Rheinheimer, C., Kohl, J., Bautsch, W., Bottger, E.C., Klos, A., IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines (1995) J. Immunol., 155, pp. 4419-4426 
504 |a Snyderman, R., Goetzl, E., Molecular and cellular mechanism of leucocyte chemotaxis (1981) Science, 213, pp. 830-837 
504 |a Fernandez, N., Monczor, F., Lemos, B., Notcovich, C., Baldi, A., Davio, C., Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation (2002) Mol. Pharmacol., 62, pp. 1506-1514 
504 |a Hong, W.K., Sporn, M.B., Recent advances in chemoprevention of cancer (1997) Science, 278, pp. 1073-1077 
504 |a Suh, N., Luyengi, L., Fong, H.H., Kinghorn, A.D., Pezzuto, J.M., Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model (1995) Anticancer Res., 15, pp. 233-239 
504 |a Rubin, J., Biskobing, D., Titus, L., Thornton, D.L., Catherwood, B.D., Nanes, M.S., 1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA (1996) Am. J. Med. Sci., 311, pp. 73-79 
504 |a Debenedetti, S.L., Palacios, P.S., Wilson, E.G., Coussio, J.D., Polyphenols of Pterocaulon polystachyum (1994) Fitoterapia, 65, pp. 188-189 
504 |a Finn, G.J., Creaven, B., Egan, D., Study of the in vitro potential of natural and synthetic coumarin derivatives, using human normal and neoplastic skin cell lines (2001) Melanoma Res., 11, pp. 461-467 
504 |a Finn, G.J., Kenealy, E., Creaven, B.S., Egan, D.A., In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines (2002) Cancer Lett., 183, pp. 61-68 
504 |a Wu, S., Lo, Y.K., Chen, C.C., Li, H.F., Chiang, H.T., Inhibitory effect of the plant-extract osthole on L-type calcium current in NG108-15 neuronal cells (2002) Biochem. Pharmacol., 63, pp. 199-206 
504 |a Thastrup, O., Knudsen, J.B., Lemmich, J., Winther, K., Inhibition of human platelet aggregation by dihydropyrano-and dihydrofuranocoumarins, a new class of cAMP-phosphodiesterase inhibitors (1985) Biochem. Pharmacol., 34, pp. 2137-2140 
504 |a Yang, E.B., Zhao, Y.N., Zhang, K., MacK, P., Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor (1999) Biochem. Biophys. Res. Commun., 260, pp. 682-685 
504 |a Chu, Y., Tsai, Y.Y., Wang, C.J., Lin, W., Tseng, T.H., Induction of apoptosis by esculetin in human leukemia cells (2001) Eur. J. Pharmacol., 416, pp. 25-32 
504 |a Jimenez-Orozco, F.A., Lopez-Gonzalez, J.S., Nieto-Rodriguez, A., Velasco-Velazquez, M.A., Molina-Guarneros, J.A., Mendoza-Patino, N., Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin (2001) Lung Cancer, 34, pp. 185-194 
520 3 |a The present study focused on the effect of a series of extracts and two 5,6,7-trioxygenated coumarins isolated from Pterocaulon polystachyum on the proliferation and differentiation of human promonocytic U-937 cells. The petroleum ether extract was the only extract that significantly reduced cell proliferation and induced cell differentiation. Treatment with pure 5-methoxy-6,7-methylenedioxycoumarin (C1) and 5-(3-methyl-2-butenyloxy)-6,7- methylenedioxycoumarin (C2), present in the petroleum ether extract, showed a time and concentration-dependent inhibition on cell proliferation. In addition, the coumarin derivatives were also able to induce CD88 functionality and NBT reduction, markers of monocytic cell differentiation. These results suggest that C1 and C2 might have a potential therapeutic role in the management of leukemia. © 2004 Elsevier Ireland Ltd. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Universidad de Buenos Aires, B419 
536 |a Detalles de la financiación: Consejo Nacional para Investigaciones Científicas y Tecnológicas, PID 792/98, 0542/98 
536 |a Detalles de la financiación: Centro de Investigación en Computación 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: We are sincerely grateful to Dr L. Bianciotti for critical reading of the manuscript. This study was supported by grants from the Universidad de Buenos Aires (grant B419); Consejo Nacional de Investigaciones Cientı́ficas y Tecnológicas, (PID 792/98, and 0542/98); and ‘Fund for Scientific Research-Flanders’ (Belgium). This work was possible by CONICET and CIC fellowships. 
593 |a Laboratorio de Radioisótopos, Fac. de Farmacia Y Bioquímica, Universidad de Buenos Aires, Junín 956 PB, 1113, Capital Federal, Buenos Aires, Argentina 
593 |a Inst. de Biol. Y Med. Experimental, Buenos Aires, Argentina 
593 |a Depto. Fisiol., Biol. Molec. Y Cel., Fac. de Ciencias Exactas Y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina 
593 |a Department of Organic Chemistry, Fac. of Agric. and Appl. Biol. Sci., Ghent University, Ghent, Belgium 
593 |a Cátedra de Farmacognosia, Facultad de Ciencias Exactas, Universidad Nacional de la Plata, Argentina 
690 1 0 |a 5-OXYGENATED-6,7-METHYLENEDIOXYCOUMARINS 
690 1 0 |a ATRA, ALL TRANS RETINOIC ACID 
690 1 0 |a CD88 
690 1 0 |a CELL DIFFERENTIATION 
690 1 0 |a DBCAMP, DIBUTYRYL CAMP 
690 1 0 |a LEUKEMIA 
690 1 0 |a NBT, NITROBLUETETRAZOLIUM 
690 1 0 |a PMA, PHORBOL 12-MYRISTATE 13-ACETATE 
690 1 0 |a PTEROCAULON POLYSTACHYUM 
690 1 0 |a 5 (3 METHYL 2 BUTENYLOXY) 6,7 METHYLENEDIOXYCOUMARIN 
690 1 0 |a 5 METHOXY 6,7 METHYLENEDIOXYCOUMARIN 
690 1 0 |a ANTINEOPLASTIC AGENT 
690 1 0 |a COMPLEMENT COMPONENT C5A RECEPTOR 
690 1 0 |a COUMARIN DERIVATIVE 
690 1 0 |a PLANT EXTRACT 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a ARTICLE 
690 1 0 |a CELL DIFFERENTIATION 
690 1 0 |a CONCENTRATION RESPONSE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a INHIBITION KINETICS 
690 1 0 |a LEUKEMIA 
690 1 0 |a LEUKEMIA CELL 
690 1 0 |a MEDICINAL PLANT 
690 1 0 |a NITROBLUE TETRAZOLIUM TEST 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PTEROCAULON POLYSTACHYUM 
690 1 0 |a ASTERACEAE 
690 1 0 |a CELL DIFFERENTIATION 
690 1 0 |a COUMARINS 
690 1 0 |a HUMANS 
690 1 0 |a LEUKEMIA, PROMYELOCYTIC, ACUTE 
690 1 0 |a MONOCYTES 
690 1 0 |a PLANT EXTRACTS 
690 1 0 |a TUMOR CELLS, CULTURED 
690 1 0 |a PTEROCAULON 
700 1 |a Shayo, C. 
700 1 |a Monczor, F. 
700 1 |a Fernández, N. 
700 1 |a Baldi, A. 
700 1 |a De Kimpe, N. 
700 1 |a Rossi, J. 
700 1 |a Debenedetti, S. 
700 1 |a Davio, C. 
773 0 |d 2004  |g v. 210  |h pp. 179-188  |k n. 2  |p Cancer Lett.  |x 03043835  |w (AR-BaUEN)CENRE-4108  |t Cancer Letters 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942555106&doi=10.1016%2fj.canlet.2004.03.015&partnerID=40&md5=a543210deabf156751c557a7a5c0d50d  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.canlet.2004.03.015  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_03043835_v210_n2_p179_Riveiro  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03043835_v210_n2_p179_Riveiro  |y Registro en la Biblioteca Digital 
961 |a paper_03043835_v210_n2_p179_Riveiro  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 65450